Adma Biologics | ADMA - Cost Of Sales

Stock Price
15.08
Daily Change
-0.10 -0.66%
Monthly
-9.05%
Yearly
-2.33%
Q1 Forecast
15.60

Adma Biologics reported $58.64M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Adma Biologics USD 58.64M 3.88M Sep/2025
Alnylam Pharmaceuticals USD 267.72M 67.57M Dec/2025
BioCryst Pharmaceuticals USD 12.27M 9.04M Dec/2024
Minerva Neurosciences 386K 31K Jun/2024
Novavax USD 60.62M 91.77M Sep/2024
Omeros USD 33.16M 18.52M Jun/2024
Takeda JPY 401.15B 184.07B Dec/2025